Sanitization procedures for pharmaceutical facilities must: Response:

Question

Options

• ABe in accordance with validation studies
• BFocus solely on areas visible to visitors
• CBe chosen based on the lowest cost
• DPrioritize the use of aesthetically pleasing sanitizers

• A
  85% (22)
• B
  8% (2)
• C
  4% (1)
• D
  4% (1)

Explanation

Sanitization procedures in pharmaceutical facilities must align with validation studies (Option A) because regulatory standards - including FDA GMP guidelines and ICH Q7 - require that cleaning and sanitization methods be scientifically validated to demonstrate they consistently achieve the intended microbial reduction. Validation studies establish the evidence base that a procedure actually works under defined conditions, which is essential for patient safety and product quality.

Why the distractors fail:

• B is wrong because sanitization must cover all critical surfaces (equipment, cleanrooms, contact surfaces), not just visitor-visible areas - contamination doesn't respect aesthetics.
• C is wrong because cost is never the governing criterion in pharmaceutical GMP; efficacy, safety, and regulatory compliance take precedence.
• D is wrong because the appearance of a sanitizer is irrelevant to its microbial kill efficacy or regulatory acceptance.

Memory tip: Think V for Validation = V for Valid pharmaceutical practice. Any procedure in pharma that touches product quality must be validated - this is the golden thread running through GMP. If an answer option sounds business-driven (cost, looks, convenience) rather than science/safety-driven, it's almost certainly wrong in a pharmaceutical context.

No community discussion yet for this question.